Contact | Sitemap

Home About BeneChill Technology Literature Clinical Studies News & Events Contact Us
About BeneChill
BeneChill's Board of Directors
BeneChill's Investors
Employment Opportunities at BeneChill
The BeneChill Management Team

Alan Raffensperger – Chief Executive Officer

An international health care executive with more than 25 years of experience in the medical/surgical device, biotechnology and diagnostic industries, Mr. Raffensperger joined BeneChill as CEO from Amgen where he was Executive Director and Franchise Head for the company’s  $1.1 billion Global Nephrology business.  He joined Amgen in 2004 as General Manager for its Nordic & Baltic Region subsidiary. Prior to Amgen, Mr. Raffensperger held executive level marketing positions with Roche Diagnostics (Global Diabetes Care) and Pharmaceuticals. Previously, he was the CEO for Swedemed, a privately held developer of advanced ultrasonic surgery systems for minimally invasive general surgery and neurosurgery.  He began his career with Pharmacia, first in sales in the U.S. and then international product management.  Mr. Raffensperger started his career in health care as a nationally registered EMT-Paramedic in Virginia. He received his Bachelor of Science degree in Emergency Health Sciences Management from the University of Maryland.

Alan Raffensperger, Chief Executive Officer

Denise Barbut, MBBS, MD, MRCP – Founder and Executive Chairman

Denise Barbut received her medical training in the United Kingdom, at the Hammersmith Hospital, the Brompton Hospital and the National Hospital for Nervous Diseases, Queen Square in London. Dr. Barbut is board certified in Internal Medicine and Neurology in the UK, and is a member of the Royal College of Physicians of Great Britain. She is a Professor of Neurology, and was formerly Cerebrovascular Division Chief and Director of the Stroke Research Program at Cornell University Medical College and Attending Physician at New York Hospital. She has published extensively in the fields of stroke and neuroprotection. Dr. Barbut is sole author or lead author of more than 200 issued or pending patents, mostly relating to methods for neuroprotection. She also has founded five biotech companies, including BeneChill.

Denise Barbut, Founder and CEO

Allan Rozenberg, Ph.D. - Chief Operating Officer

Allan Rozenberg has more than 23 years of experience in the research and development of biomedical instrumentation used in the monitoring, testing and delivering of therapy to critically ill patients. Before joining BeneChill, he was the Director of Biomedical Engineering at Metracor Technologies and previously, he was a Principal Scientist at Alliance Pharmaceutical Corp. where he worked on devices for liquid ventilation and pulmonary delivery of perfluorocarbons. Dr. Rozenberg holds a Bachelor of Arts degree in Biomedical Statistics, a Master of Science in Health Informatics and a Doctorate in Biomedical Engineering from the University of Minnesota.

Allan Rozenberg, Chief Operating Officer

Becky Inderbitzen, MSE – Vice President of Clinical Affairs

Becky Inderbitzen has more than 20 years of experience in the research and development of life support equipment and medical devices, with an emphasis on preclinical and clinical testing. She brings key experience from InnerCool Therapies where she oversaw the preclinical development of an endovascular thermoregulatory system and directed clinical studies utilizing therapeutic hypothermia in neurointensive and acute care settings. Prior to InnerCool, she had extensive involvement in the preclinical development of interventional and minimally invasive surgical cardiovascular devices for Guidant. Ms. Inderbitzen holds both Bachelor and Master of Science degrees in Biomedical Engineering from Duke University and University of Southern California, respectively.

Becky Inderbitzen, Vice President of Clinical Affairs

John Hoffman - Vice President of Research and Development

John Hoffman holds degrees in electrical and mechanical engineering and has over 24 years experience developing equipment and instrumentation in the fields of Medical Research, Physical Sciences and Semiconductor Processing. Most recently he was a Senior Project Engineer at RoboDesign. Prior to that he was a Principal Engineer at Alliance Pharmaceutical, where he was developing devices for liquid ventilation.

John Hoffman, Dir. of Research & Development

Nevine Erian, MSQA, MBA - Vice President of Quality and Manufacturing

Nevine Erian has over 18 years of Engineering, Quality Management and Regulatory Compliance experience. Prior to joining BeneChill, Ms. Erian held various leadership positions in medical devices, including Vice President of Quality at ASP, Johnson & Johnson and Vice President of Quality Systems and Technical Operations at Del Mar Medical Systems. Her medical device experience includes disposables, implants, consumables and capital equipment. Ms. Erian holds a Masters of Science in Quality Assurance, a Masters of Business Administration and a Bachelors of Science in Electrical Engineering. She is a Certified Quality Engineer by American Society for Quality. Ms. Erian is an active member of Orange County Regulatory Affairs (OCRA) Discussion Group. She is also a member of Regulatory Affairs Professional Society (RAPS) and American Society for Quality (ASQ).

Nevine Erian, Dir. of Quality Assurance

Charles Anderson - Director of Manufacturing

Charles Anderson is an MS Chemical Engineer with extensive experience in introducing new products in the medical device, diagnostic and pharmaceutical industries. He has 30 years of experience in working with Scientific, Marketing and Regulatory professionals to create orderly development paths from R&D to approved manufacturing operations.

Charles Anderson, Dir. of Manufacturing
 

Home :: About BeneChill :: Technology :: Literature :: Clinical Studies :: News & Events :: Contact Us :: Sitemap

View our policies: Code of Ethics | Privacy | Online Terms & Conditions
Copyright © 2010 BeneChill, Inc. All rights reserved.
Site designed by The MarketBuilding Team.
Questions or comments about this site? Contact the Webmaster.